In the News


Read the latest articles featuring MTPConnect.


3D Printing And Precision Medicine To Get $5m In Government Funding

The Australian | 1 November 2017

Managed by MTPConnect, the $5m BioMedTech Horizons program will be managed by MTPConnect, the medical technologies and pharmaceuticals industry growth centre. MTPConnect chief executive Sue MacLeman spoke to The Australian, saying that 3D anatomical printing and precision medicine had been identified for the first share of funding because Australia punched above its weight in those areas.

Cancer Test Platform among Recipients in $22.5m Tech Funding Round For MTPConnect

Australian Financial Review | 26 October 2017

Our CEO Sue MacLeman talks about a MTPConnect Project Fund Program lead The Garvan Institute aimed to improve cancer clinical trial research.

AISC's new training package for pharma manufacturing Businesses

Manufacturer's Monthly | 11 August 2017

Our General Manager of Education, Skills and Events Dr Melanie Thomson about the training that will save pharmaceutical manufacturing businesses time and money by allowing employees to transfer basic skills between companies.

Pharma research play translates into jobs and growth

The Mandarin | 7 August 2017

An article discussing our Clinical Trials Report and how it aims to turn Australia around to be a destination for jobs and pharmaceutical investment in clinical trials.

Grant boost for medical research

Business News Western Australia | 1 November 2016

The MTPConnect Project Fund Program has provided a local WA consortium with a $150,000 grant to improve commercialisation of pharmaceutical and medical technologies.

New funding mechanism could create needed life sciences ecosystem

BioWorld | 28 October 2016

The Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) announced at the recent AusBiotech annual conference that it would provide A$7.4 million (US$5.6 million) of funding over two years for 14 national projects in the med-tech, biotech and pharmaceutical sector, with the Australian government injecting more funding into its life sciences sector to help it become more globally competitive in commercializing products.

$43.4 million announced to drive innovation in pharmaceuticals and medtech around Australia

StartUp Smart | 24 October 2016

Growing investment in medical technology and pharmaceutical innovation is set to fire a new pipeline of high-impact ventures into Australia that have been hiding in the corridors of universities waiting to be commercialised. This week, non-profit organisation MTPConnect announced it will inject $7.4 million into 14 medtech, biotech and pharmaceutical projects over the next two years. The funding will be matched by a further $32 million from industry partners under MTP Connect’s project fund program.

Pill boxes and 'kneehab' apps: Johnson & Johnson hackathon

Australian Financial Review | 26 September 2016

Our CEO Sue MacLeman comments on the recent Federal Government response to the Review of Medicines and Medical Devices Regulation in this article highlighting Johnson & Johnson's potential commercialisation of two winning inventions from a hackathon earlier this month.

Forging better MedTech links

InnovationAus | 30 June 2016

Our CEO Sue MacLeman talked to InnovationAus about the achievements and challenges of the MTP sector and how MTPConnect will increase collaboration and commercialisation efforts.

A boost for innovation in medical technologies and pharmaceuticals sector

University of Sydney | 11 December 2015

Australia’s newest Growth Centre – the Medical Technologies and Pharmaceutical Industry Growth Centre – has been announced by the Hon. Christopher Pyne, Federal Minister for Industry, Innovation and Science and Minister for Health, Sussan Ley.